BTNL8
Butyrophilin-like protein 8
Protein Summary
May stimulate primary immune response. Acts on T-cell stimulated sub-optimally through the TCR/CD3 complex stimulating their proliferation and cytokine production.
- ENST00000231229
- ENSP00000231229
- ENSG00000113303
- ENST00000340184
- ENSP00000342197
- ENST00000400707
- ENSP00000383543
- ENST00000508408
- ENSP00000424585
- ENST00000511704
- ENSP00000425207
- ENST00000533815
- ENSP00000435098
- ENST00000610640
- ENSP00000483717
- BTN9.2
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
|---|---|---|---|
protein domain | 0.99 | ||
tissue sample | 0.67 | ||
cell type or tissue | 0.56 | ||
cell line | 0.52 | ||
phenotype | 0.49 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 4.38 (req: < 5)
Gene RIFs: 2 (req: <= 3)
Antibodies: 141 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 4.38 (req: >= 5)
Gene RIFs: 2 (req: > 3)
Antibodies: 141 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 4
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligand: 0
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0